School of Dentistry researchers in collaboration from researchers from the School of Medicine’s Departments of Biomedical Engineering and Physiology & Pharmacology published a study in The Journal of Neuroscience Research that is the first to link blood pressure with the production and secretion of a protein in nerve cells known as BDNF, or Brain-Derived Neurotrophic Factor. It appears that pressure-sensitive nerve cell production of BDNF increases substantially during hypertension, which suggests that this research has serious implications for the … Read More
Posts Tagged ‘publications’
The OHSU Library has published a guide on the NIH Public Access Policy, offering a one-stop resource for understanding the Policy and its requirements. The guide provides beginning to end compliance instructions, step-by-step directions for submitting a manuscript to PubMedCentral, and an overview of the Library’s Policy services. Robin Champieux, scholarly communication librarian, is also available to answer your Policy related questions at (503) 494-2770.
This week’s video shows you how to look up an OHSU researcher’s publication history in SciVal Experts. Learn more about SciVal Experts, or watch last week’s tutorial.
Three OHSU ontologists had their study, “Dealing with Data: A Case Study on Information and Data Management Literacy,” featured in the Public Library of Science (PLoS) Biology journal. Congratulations! Visit the School of Medicine Research Voice blog to learn more.
Researchers at the Oregon National Primate Research Center have created a new vaccine development technique using a solution previously thought too damaging to be useful in vaccine production. Mark Slifka, Ph.D., and colleagues have successfully utilized hydrogen peroxide as a virus inactivator in the generation of three distinct vaccines. Vaccines for West Nile, Lymphocytic choriomeningitis, and vaccinia viruses have been created using this new technique, which supports the researchers’ claims that this could truly be a new platform technology … Read More
A new study, published in the New England Journal of Medicine, found that 63 percent of multiple myeloma patients have a reduced risk of disease progression or death if treated with lenalidomide (Revlimid®) following a stem cell transplant. The study was co-authored by Richard Mariarz, MD, medical director of the Adult Stem Cell Transplantation Program & Center for Hematologic Malignancies at the Knight Cancer Institute. Read the OHSU News Release to learn more.
Two OHSU researchers, Fay Horak, Ph.D., professor of neurology, and Robert Peterka, Ph.D., associate professor of biomedical engineering, were recently recognized by the American Physiological Society for having highly cited publications in the Journal of Neurophysiology. Dr. Horak’s paper, “Central programming of postural movements: Adaptation to altered support-surface configurations,” was one of the top ten cited papers from 1980-1989, and Dr. Peterka’s, “Sensorimotor integration in human postural control,” was one of the top ten from 2000 to 2011. … Read More